Erectile dysfunction in patient with obstructive sleep apnea: effects of continuous positive airway pressure.

BACKGROUND: Obstructive sleep apnea (OSA) is linked to various health complications, including erectile dysfunction (ED), which is more prevalent in individuals with OSA. This study explored ED in Korean OSA patients and assessed the impact of continuous positive airway pressure (CPAP) therapy on ED. METHODS: A total of 87 male patients with OSA from four different sleep centers underwent physical measurements and completed sleep and mental health (MH) questionnaires, including the Korean version of the International index of erectile function (IIEF), before and three months after initiating CPAP therapy. RESULTS: After three months of CPAP therapy, the patients demonstrated a significant improvement in ED as measured on the IIEF. However, the study found no significant correlation between the duration of CPAP use and the improvement in IIEF score. It did identify the SF36 quality of life assessment as a significant factor influencing ED improvement after CPAP. CONCLUSIONS: ED is a prevalent issue that escalates with age and is associated with OSA. CPAP therapy has shown potential in alleviating ED symptoms, particularly in those with underlying psychological conditions, although further research is required to confirm these findings and understand the underlying mechanisms.

High-Frequency Vibrating Stimuli Using the Low-Cost Coin-Type Motors for SSSEP-Based BCI.

Steady-state somatosensory-evoked potential- (SSSEP-) based brain-computer interfaces (BCIs) have been applied for assisting people with physical disabilities since it does not require gaze fixation or long-time training. Despite the advancement of various noninvasive electroencephalogram- (EEG-) based BCI paradigms, researches on SSSEP with the various frequency range and related classification algorithms are relatively unsettled. In this study, we investigated the feasibility of classifying the SSSEP within high-frequency vibration stimuli induced by a versatile coin-type eccentric rotating mass (ERM) motor. Seven healthy subjects performed selective attention (SA) tasks with vibration stimuli attached to the left and right index fingers. Three EEG feature extraction methods, followed by a support vector machine (SVM) classifier, have been tested: common spatial pattern (CSP), filter-bank CSP (FBCSP), and mutual information-based best individual feature (MIBIF) selection after the FBCSP. Consequently, the FBCSP showed the highest performance at 71.5 ± 2.5% for classifying the left and right-hand SA tasks than the other two methods (i.e., CSP and FBCSP-MIBIF). Based on our findings and approach, the high-frequency vibration stimuli using low-cost coin motors with the FBCSP-based feature selection can be potentially applied to developing practical SSSEP-based BCI systems.

Development of the clinical assessment scale in autoimmune encephalitis.

OBJECTIVE: There is no scale for rating the severity of autoimmune encephalitis (AE). In this study, we aimed to develop a novel scale for rating severity in patients with diverse AE syndromes and to verify the reliability and validity of the developed scale. METHODS: The key items were generated by a panel of experts and selected according to content validity ratios. The developed scale was initially applied to 50 patients with AE (development cohort) to evaluate its acceptability, reproducibility, internal consistency, and construct validity. Then, the scale was applied to another independent cohort (validation cohort, n = 38). RESULTS: A new scale consisting of 9 items (seizure, memory dysfunction, psychiatric symptoms, consciousness, language problems, dyskinesia/dystonia, gait instability and ataxia, brainstem dysfunction, and weakness) was developed. Each item was assigned a value of up to 3 points. The total score could therefore range from 0 to 27. We named the scale the Clinical Assessment Scale in Autoimmune Encephalitis (CASE). The new scale showed excellent interobserver (intraclass correlation coefficient [ICC] = 0.97) and intraobserver (ICC = 0.96) reliability for total scores, was highly correlated with modified Rankin scale (r = 0.86, p < 0.001), and had acceptable internal consistency (Cronbach α = 0.88). Additionally, in the validation cohort, the scale showed high interobserver reliability (ICC = 0.99) and internal consistency (Cronbach α = 0.92). INTERPRETATION: CASE is a novel clinical scale for AE with a high level of clinimetric properties. It would be suitable for application in clinical practice and might help overcome the limitations of current outcome scales for AE. ANN NEUROL 2019;85:352-358.